Sorry, you need to enable JavaScript to visit this website.

A-56-14

A-56-14 In re: Reglan Litigation (075269)

Are plaintiffs’ failure-to-warn claims against manufacturers of a generic prescription drug preempted by federal law?

Watch the 
  • Leave to appeal granted : April 24, 2015
  • Posted: April 27, 2015
  • Argued: April 11, 2016
  • Decided: Aug. 22, 2016